Web
AlphaID
Audience: HCP
Condition: Alpha-1 antitrypsin (AAT) deficiency
Unbranded: PROLASTIN®-C, Grifols
Lead copy for the site redesign, including the addition of Why Screen, Resources, site callouts, request a rep and kit ordering forms.
LEMTRADA
Audience: Consumer
Condition: Relapsing Multiple Sclerosis
Branded: Regeneron
Restructured and rewrote the entirety of LEMTRADA's HCP and patient websites, navigating complex FDA black box requirements.
LEMTRADA
Audience: HCP
Condition: Relapsing Multiple Sclerosis
Branded: Regeneron
Restructured and rewrote the entirety of LEMTRADA's HCP and patient websites, navigating complex FDA black box requirements.
Eczema Exposed
Audience: Consumer
Condition: Eczema
Unbranded: DUPIXENT, Regeneron
Refocused DUPIXENT’s eczema disease education site with new content to promote the indication’s expansion to pediatric populations.
LIBTAYO
Audience: HCP
Condition: Non–small cell lung cancer (NSCLC)
Branded: Regeneron
After LIBTAYO's approval as a frontline combination therapy for NSCLC, based on EMPOWER-LUNG 3 trial results, I developed and integrated new clinical data content. I also managed content for LIBTAYO's cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC) indications.
